5741 - 5750 of 6255 Results
Title
Year
- Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformations2022OPENTitle: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformationsJournal Name: Protein SciencePublisher: WileyVol: 31Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pro.4360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.4360Citation Count: 9
- Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissues2023OPENTitle: Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissuesJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 42Issue #: 1Start Page: 109End Page: 118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41587-023-01751-6Best OA location URL: https://www.nature.com/articles/s41587-023-01751-6.pdfCitation Count: 34
-
OPENTitle: Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the BrainJournal Name: Molecular Therapy - Methods & Clinical DevelopmentPublisher: Elsevier BVVol: 11Issue #:Start Page: 29End Page: 39Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtm.2018.08.008Best OA location URL: http://www.cell.com/article/S2329050118300895/pdfCitation Count: 17
- Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers2016OPENTitle: Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 HeteromersJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1201End Page: 1211Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00036Best OA location URL: http://doi.org/10.1021/acschemneuro.6b00036Citation Count: 57
-
OPENTitle: Progression of regional cortical cholinergic denervation in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/braincomms/fcac320Best OA location URL: https://doi.org/10.1093/braincomms/fcac320Citation Count: 25
-
OPENTitle: Incidence of Parkinson disease in North AmericaJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00410-yBest OA location URL: https://escholarship.org/content/qt3pz049xw/qt3pz049xw.pdfCitation Count: 188
- The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders2024OPENTitle: The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disordersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 8Start Page: 2775End Page: 2790Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1093/brain/awae056Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae056/56907442/awae056.pdfCitation Count: 7
- Differential cholinergic systems’ changes in progressive supranuclear palsy versus Parkinson’s disease: an exploratory analysis2022OPENTitle: Differential cholinergic systems’ changes in progressive supranuclear palsy versus Parkinson’s disease: an exploratory analysisJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 129Issue #: 12Start Page: 1469End Page: 1479Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-022-02547-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10017092Citation Count: 6
- α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s disease2024OPENTitle: α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00756-2Best OA location URL: https://doi.org/10.1186/s13024-024-00756-2Citation Count: 10
- Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluency2010OPENTitle: Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluencyJournal Name: NeuroImagePublisher: Elsevier BVVol: 54Issue #:Start Page: S238End Page: S246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2010.03.068Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2908727Citation Count: 111